National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Blood Stem Cell Transplants
< Back to Main
In English En español
    Posted: 09/01/2006    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Slide 7 : Not Just Any Blood Stem Cells Will Do previousnext

The success of a blood stem cell transplant relies upon the interactions of markers on the surface of all body cells, including the immune cells of both the patient and the donor. Normally, all cells within the patient's body coexist peacefully in a state known as self-tolerance because all bear the same "self" marker proteins. These proteins are also called antigens because, should they be introduced into a new environment, they are capable of stimulating a powerful immune reaction. This is what occurs when a blood stem cell preparation with "non-self" antigens is transplanted into a patient whose "self" antigens are very different.

Not Just Any Blood Stem Cells Will Do

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov